Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-17

Clinical Trial Update: Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating sulforaphane for lung cancer chemoprevention in former smokers. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulforaphane (sulforaphane)

Snippet

Sponsor: Jian-Min Yuan, MD | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-12-17